| Term 
 
        | What are the three CYP (P450) families involved in drug (xenobiotic) metabolism? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which P450 enzyme metabolizes the largest percentage of marketed drugs? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What will induce the CYP1 family? |  | Definition 
 
        | Cigarette smoke, polycyclic aromatic hydrocarbons, charred meats, omeprazole (think burnt)
 |  | 
        |  | 
        
        | Term 
 
        | What will induce the CYP2D subfamily? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What will induce the CYP2A,CYP2B,or CYP2C subfamilies? |  | Definition 
 
        | Barbiturates (phenobarbitol), Rifampin |  | 
        |  | 
        
        | Term 
 
        | What will induce the CYP2E subfamily? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What will induce the CYP3A subfamily? |  | Definition 
 
        | Barbiturates, Rifampin, Carbamazepine, St. John’s Wort, Efavirenz |  | 
        |  | 
        
        | Term 
 
        | What happens during enzyme induction? |  | Definition 
 
        | Increased enzymatic activity (metabolism) which leads to: - Increased transcription
 - Increased translation
 - Decreased protein degradation
 And in the case of our drugs, a decrease in drug concentration and bioavailability.
 |  | 
        |  | 
        
        | Term 
 
        | Which CYPs have polymorphism? |  | Definition 
 
        | CYP2D6 and also:
 CYP2C9
 CYP2C19
 CYP2A6
 |  | 
        |  | 
        
        | Term 
 
        | What is the effect of an INHIBITOR on the drug? |  | Definition 
 
        | Increases bioavailability |  | 
        |  | 
        
        | Term 
 
        | What is the effect of an INDUCER on the drug? |  | Definition 
 
        | Decreases bioavailability |  | 
        |  |